Know Error not covered by Medicare!

Quote






I just heard the same news about one of my accounts. The practice received a letter today from Medicare stating that Know Error's service would no longer be paid by Medicare. That means it's just a matter of time before all other payers follow suit. I wonder whether they're just denying coverage for Know Error due to abuses or if they're denying payment across the board for DNA matching. My understanding is that Know Error performs DNA matching on all positives, which seems excessive, rather than testing only one per patient.
 


















Know Error is still around and growing. The company recommends testing of every positive core because each core can differ in it's stage of cancer. If, for example, a high grade positive core belongs to different person, a less than optimal treatment plan could be prescribed for each person. Each pathology mistake (or doctor's office mistake) effects two people. Error rates average between 1-3% which effects thousands of people each year.
 












I guess the bottom line is this: if you were diagnosed with cancer, would you want to make sure the diagnosis was really yours and not the result of an error (whether the testing is performed by this company or another)? I would absolutely want to have this piece of mind when facing chemo and/or invasive surgery. Yes, testing is expensive. Whether to have DNA testing performed is ultimately up to the patient.
 






Anonymous said:
I guess the bottom line is this: if you were diagnosed with cancer, would you want to make sure the diagnosis was really yours and not the result of an error (whether the testing is performed by this company or another)? I would absolutely want to have this piece of mind when facing chemo and/or invasive surgery. Yes, testing is expensive. Whether to have DNA testing performed is ultimately up to the patient.
Click to expand...

This is jackass reasoning for the DNA test offered by know error. Mislabeling of the biopsy tissue by the original pathology lab is subject to a very small possibility of error. Drawing a patient's blood for white cells to perform DNA fingerprinting is also fraught with possibility for error. Adding on an additional outrageously expensive test to confirm that no error occurred during prostate biopsy specimen collection or processing is crippled by the fact that additional preanalytical labeling errors can occur for this additional genetic testing as well. Let's say the blood tube collected for DNA fingerprint comparison gets mislabeled and mixed up with another patient's blood tube. Then a patient gets a discordant result using the "know error" DNA fingerprinting test, when the biopsy tissue is truly their own.

This abomination of a test may represent the very apogee of outrageous, expensive, and inefficient diagnostic testing advocated by greedy physicians and businessmen who benefit financially from excessive, medically unnecessary testing. It figures that a smarmy urology group that profiteers off of performing mountains of medically unnecessary lab testing came up with it. What a joke.
 






Non-matches are always rechecked with new reference DNA collected from the patient and additional tissue sent from the pathology lab. In addition, exhaustive retesting of the original samples occurs. Pathology labs have no way to check for mix-ups between patients on their own which is why these labs have sent suspected tissue mix-ups to DNA labs for years.
 






Anonymous said:
This is jackass reasoning for the DNA test offered by know error. Mislabeling of the biopsy tissue by the original pathology lab is subject to a very small possibility of error. Drawing a patient's blood for white cells to perform DNA fingerprinting is also fraught with possibility for error. Adding on an additional outrageously expensive test to confirm that no error occurred during prostate biopsy specimen collection or processing is crippled by the fact that additional preanalytical labeling errors can occur for this additional genetic testing as well. Let's say the blood tube collected for DNA fingerprint comparison gets mislabeled and mixed up with another patient's blood tube. Then a patient gets a discordant result using the "know error" DNA fingerprinting test, when the biopsy tissue is truly their own.

This abomination of a test may represent the very apogee of outrageous, expensive, and inefficient diagnostic testing advocated by greedy physicians and businessmen who benefit financially from excessive, medically unnecessary testing. It figures that a smarmy urology group that profiteers off of performing mountains of medically unnecessary lab testing came up with it. What a joke.
Click to expand...

A few Months back Consumer Reports did a series on Unnecessary lab tests for cancer. They all but slammed Urology as being the biggest culprit. I wonder what they would think of this test.
Word to the wise...Back in the day when PAPS were switching technology both NEOPATH and the really ridiculous PAPNET tried to sell by belittling Pathologists and Laboratories...What ever happened to them....Lots of unhappy investors and pissed of professionals...
 






Anonymous said:
A few Months back Consumer Reports did a series on Unnecessary lab tests for cancer. They all but slammed Urology as being the biggest culprit. I wonder what they would think of this test.
Word to the wise...Back in the day when PAPS were switching technology both NEOPATH and the really ridiculous PAPNET tried to sell by belittling Pathologists and Laboratories...What ever happened to them....Lots of unhappy investors and pissed of professionals...
Click to expand...

Hey, those two are both part of Tripath Imaging which is now part of BD.
Focal Point and Surepath are the legacy cytology names and both are not doing so well right now.
 






Anonymous said:
This is jackass reasoning for the DNA test offered by know error. Mislabeling of the biopsy tissue by the original pathology lab is subject to a very small possibility of error. Drawing a patient's blood for white cells to perform DNA fingerprinting is also fraught with possibility for error. Adding on an additional outrageously expensive test to confirm that no error occurred during prostate biopsy specimen collection or processing is crippled by the fact that additional preanalytical labeling errors can occur for this additional genetic testing as well. Let's say the blood tube collected for DNA fingerprint comparison gets mislabeled and mixed up with another patient's blood tube. Then a patient gets a discordant result using the "know error" DNA fingerprinting test, when the biopsy tissue is truly their own.

This abomination of a test may represent the very apogee of outrageous, expensive, and inefficient diagnostic testing advocated by greedy physicians and businessmen who benefit financially from excessive, medically unnecessary testing. It figures that a smarmy urology group that profiteers off of performing mountains of medically unnecessary lab testing came up with it. What a joke.
Click to expand...

Your a jackass, you dont even know how the test is performed..LOL on blood? Hmm.. Im collecting cellular material for your pap,... give me some blood so I can get your DNA.

Your a blow-hard, know nothing, spouting your ameoba sh*t all over an anonymous board. What a loser.
 






Anonymous said:
Your a jackass, you dont even know how the test is performed..LOL on blood? Hmm.. Im collecting cellular material for your pap,... give me some blood so I can get your DNA.

Your a blow-hard, know nothing, spouting your ameoba sh*t all over an anonymous board. What a loser.
Click to expand...

Pot kettle black
Keep on losing
 






Top Bottom
Back
Quote